IDEXX Laboratories Inc (IDXX)
Operating return on assets (Operating ROA)
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 1,130,058 | 1,113,674 | 1,085,065 | 1,115,687 | 1,097,128 | 1,078,353 | 1,047,898 | 930,820 | 898,765 | 871,429 | 852,563 | 932,750 | 932,028 | 917,932 | 863,826 | 797,821 | 694,524 | 625,060 | 593,006 | 564,033 |
Total assets | US$ in thousands | 3,293,440 | 3,350,770 | 3,414,870 | 3,353,520 | 3,259,920 | 3,086,400 | 2,870,810 | 2,808,400 | 2,746,760 | 2,640,070 | 2,607,180 | 2,592,690 | 2,437,200 | 2,385,740 | 2,412,150 | 2,327,380 | 2,294,560 | 2,047,410 | 1,960,710 | 1,886,240 |
Operating ROA | 34.31% | 33.24% | 31.77% | 33.27% | 33.66% | 34.94% | 36.50% | 33.14% | 32.72% | 33.01% | 32.70% | 35.98% | 38.24% | 38.48% | 35.81% | 34.28% | 30.27% | 30.53% | 30.24% | 29.90% |
December 31, 2024 calculation
Operating ROA = Operating income (ttm) ÷ Total assets
= $1,130,058K ÷ $3,293,440K
= 34.31%
IDEXX Laboratories Inc has shown consistent performance in terms of Operating Return on Assets (Operating ROA) over the analyzed periods from March 31, 2020, to December 31, 2024. The company's Operating ROA fluctuated within a range, indicating varying efficiency in generating operating profits from its assets.
The trend of IDEXX's Operating ROA demonstrates an initial increase from 29.90% in March 2020 to a peak of 38.48% in September 2021. This growth trend suggests improved operational efficiency and profitability during this period. Subsequently, there was a slight decline in Operating ROA to 32.70% in June 2022 before it increased again to 36.50% in June 2023.
However, IDEXX experienced a decline in Operating ROA in the latter part of the analyzed period, with a decrease to 31.77% in June 2024, followed by a subsequent increase to 34.31% in December 2024. Overall, IDEXX Laboratories Inc has maintained a relatively strong level of Operating ROA, indicating the company's ability to effectively utilize its assets to generate operating profits.
It is essential for stakeholders to closely monitor IDEXX's Operating ROA in conjunction with other financial metrics to assess the company's operational efficiency and performance in generating profits relative to its asset base.
Peer comparison
Dec 31, 2024